Geode Capital Management’s Y-mAbs Therapeutics YMAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$3.83M Sell
848,461
-1,039
-0.1% -$4.69K ﹤0.01% 2870
2025
Q1
$3.76M Buy
849,500
+27,191
+3% +$120K ﹤0.01% 2793
2024
Q4
$6.44M Buy
822,309
+8,820
+1% +$69.1K ﹤0.01% 2621
2024
Q3
$10.7M Buy
813,489
+47,846
+6% +$629K ﹤0.01% 2338
2024
Q2
$9.25M Buy
765,643
+22,894
+3% +$277K ﹤0.01% 2367
2024
Q1
$12.1M Buy
742,749
+4,201
+0.6% +$68.3K ﹤0.01% 2207
2023
Q4
$5.04M Buy
738,548
+27,715
+4% +$189K ﹤0.01% 2702
2023
Q3
$3.87M Sell
710,833
-831
-0.1% -$4.53K ﹤0.01% 2770
2023
Q2
$4.83M Buy
711,664
+49,019
+7% +$333K ﹤0.01% 2696
2023
Q1
$3.32M Buy
662,645
+31,351
+5% +$157K ﹤0.01% 2812
2022
Q4
$3.08M Sell
631,294
-1,601
-0.3% -$7.81K ﹤0.01% 2890
2022
Q3
$9.13M Buy
632,895
+6,727
+1% +$97K ﹤0.01% 2318
2022
Q2
$9.47M Buy
626,168
+42,639
+7% +$645K ﹤0.01% 2287
2022
Q1
$6.93M Sell
583,529
-37,448
-6% -$445K ﹤0.01% 2599
2021
Q4
$10.1M Buy
620,977
+43,866
+8% +$711K ﹤0.01% 2448
2021
Q3
$16.5M Buy
577,111
+26,064
+5% +$744K ﹤0.01% 2093
2021
Q2
$18.6M Buy
551,047
+76,929
+16% +$2.6M ﹤0.01% 2015
2021
Q1
$14.3M Buy
474,118
+43,240
+10% +$1.31M ﹤0.01% 2097
2020
Q4
$21.3M Buy
430,878
+29,701
+7% +$1.47M ﹤0.01% 1680
2020
Q3
$15.4M Buy
401,177
+42,614
+12% +$1.64M ﹤0.01% 1707
2020
Q2
$15.5M Buy
358,563
+51,241
+17% +$2.21M ﹤0.01% 1670
2020
Q1
$8.02M Buy
307,322
+35,104
+13% +$916K ﹤0.01% 1874
2019
Q4
$8.51M Buy
272,218
+68,016
+33% +$2.13M ﹤0.01% 2126
2019
Q3
$5.32M Buy
204,202
+39,223
+24% +$1.02M ﹤0.01% 2348
2019
Q2
$3.77M Buy
164,979
+75,509
+84% +$1.73M ﹤0.01% 2575
2019
Q1
$2.35M Buy
89,470
+11,438
+15% +$300K ﹤0.01% 2765
2018
Q4
$1.59M Buy
+78,032
New +$1.59M ﹤0.01% 2894